TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8622104

Group type: EXPERIMENTAL
Intervention: Isepamicin (15 mg/kg or 8 mg/kg once daily)
Number of subjects: 252

Group type: COMPARATOR
Intervention: Amikacin (7.5 mg/kg twice daily)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Isepamicin
Number of subjects: 252

Group type: COMPARATOR
Intervention: Amikacin
Number of subjects: 252
Study: 1674105

Group type: EXPERIMENTAL
Intervention: Ursodiol (13 to 15 mg per kilogram of body weight per day)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Ursodiol
Number of subjects: 146
Study: 6156324

Group type: EXPERIMENTAL
Intervention: Dopamine 4 microgram/kg/min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dopamine 8 microgram/kg/min
Number of subjects: 10
Study: 31911147

Group type: EXPERIMENTAL
Intervention: Islatravir (0.5-30 mg single oral dose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Islatravir (10 mg dose)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Islatravir (0.5 mg dose)
Number of subjects: 30
Study: 30408421

Group type: EXPERIMENTAL
Intervention: Bone-cement K-wire fixation
Number of subjects: 107

Group type: COMPARATOR
Intervention: Plate-and-screw system
Number of subjects: 107
Study: 28499772

Group type: EXPERIMENTAL
Intervention: Patient Advocate Intervention (PAI)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 102
Study: 25657175

Group type: EXPERIMENTAL
Intervention: Lipid-lowering therapy (baseline treatment)
Number of subjects: 3184
Study: 23835929

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 33

Group type: COMPARATOR
Intervention: No chemotherapy
Number of subjects: 33
Study: 21362575

Group type: EXPERIMENTAL
Intervention: Fish oil lipid emulsion (10% fish oil, 50% medium‐chain triacylglycerols, 40% soybean oil)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Soybean oil (standard preparation, 50:50 medium‐chain triacylglycerols: soybean oil)
Number of subjects: 47
Study: 18640856

Group type: EXPERIMENTAL
Intervention: Acetaminophen extended-release (APAP ER) 3900 mg daily
Number of subjects: 403

Group type: COMPARATOR
Intervention: Rofecoxib 12.5 mg daily
Number of subjects: 403

Group type: COMPARATOR
Intervention: Rofecoxib 25 mg daily
Number of subjects: 403
Study: 17538978

Group type: EXPERIMENTAL
Intervention: Neoadjuvant endocrine therapy with aromatase inhibitors (anastrozole 1 mg/day or exemestane 25 mg/day for 3 months)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Neoadjuvant chemotherapy (doxorubicin 60 mg/m(2) with paclitaxel 200 mg/m(2) for four 3-week cycles)
Number of subjects: 121
Study: 14738791

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (500 mg per day for 5 days)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo (for 5 days)
Number of subjects: 233
Study: 15801935

Group type: EXPERIMENTAL
Intervention: CHF3381 400 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CHF3381 100 mg twice daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: CHF3381 200 mg twice daily
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 10477360

Group type: EXPERIMENTAL
Intervention: Carbohydrate‐arginine (CHO/AA) supplement (1 g carbohydrate/kg body mass and 0.08 g arginine‐hydrochloride/kg body weight)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Carbohydrate (CHO) supplement (1 g carbohydrate/kg body weight)
Number of subjects: 12
Study: 8916825

Group type: EXPERIMENTAL
Intervention: Granisetron 40 micrograms.kg-1 intravenously
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Granisetron 10 micrograms.kg-1 intravenously
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 1886351

Group type: COMPARATOR
Intervention: Indomethacin 1% (Indoptic)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 0.03% (Ocuflur)
Number of subjects: 40
Study: 6407352

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Lithium plus oxymetholone
Number of subjects: 213

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 213
Study: 30837170

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine with 45 μg of LTh(αK)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control vaccine (22.5 μg of influenza HA antigen alone)
Number of subjects: 36
Study: 29061153

Group type: EXPERIMENTAL
Intervention: Large Group (LG) - 100 persons
Number of subjects: 195

Group type: COMPARATOR
Intervention: Small Group (SG) - 20 persons (4 groups)
Number of subjects: 195
Study: 27586538

Group type: EXPERIMENTAL
Intervention: (S)-amlodipine (2.5-5 mg)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Conventional amlodipine (5-10 mg)
Number of subjects: 172
Study: 24952863

Group type: EXPERIMENTAL
Intervention: Prasugrel
Number of subjects: 7062

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 7062
Study: 22427146

Group type: EXPERIMENTAL
Intervention: Ozil Intelligent Phaco (IP) torsional mode
Number of subjects: 60

Group type: COMPARATOR
Intervention: Combined torsional/longitudinal ultrasound (US) mode
Number of subjects: 60
Study: 19588080

Group type: EXPERIMENTAL
Intervention: Structured psychosomatic diagnostics and verbal intervention (group 1, n=27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (group 2, n=27) - medical examination and consultation
Number of subjects: 54
Study: 17689812

Group type: EXPERIMENTAL
Intervention: Educational intervention for primary care professionals
Number of subjects: 4060
Study: 15193814

Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 11588130

Group type: EXPERIMENTAL
Intervention: Fenretinide for 1 year
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 120
Study: 9613231

Group type: EXPERIMENTAL
Intervention: Blink-free saccades
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Blink-concurrent glissadic saccades
Number of subjects: 16
Study: 8006235

Group type: EXPERIMENTAL
Intervention: All-Bond 2 with dentin etch
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All-Bond 2 without dentin etch
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Scotchbond 2
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi-Purpose
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enamel Bond with dentin etch (Control)
Number of subjects: 16
Study: 29624413

Group type: EXPERIMENTAL
Intervention: Frontal crash prevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lane maintenance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Blind spot detection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All 3 technologies combined
Number of subjects: 0
Study: 26457558

Group type: EXPERIMENTAL
Intervention: Everolimus-eluting bioresorbable vascular scaffold (Absorb)
Number of subjects: 2008

Group type: COMPARATOR
Intervention: Everolimus-eluting cobalt-chromium stent (Xience)
Number of subjects: 2008
Study: 24035052

Group type: EXPERIMENTAL
Intervention: One-hand chest compression while continuously maintaining an open airway (OCOA)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Standard CPR (Control Group A)
Number of subjects: 193
Study: 20973032

Group type: EXPERIMENTAL
Intervention: Mental Health Continuum-Short Form (MHC-SF)
Number of subjects: 1662
Study: 18164819

Group type: EXPERIMENTAL
Intervention: Yohimbine hydrochloride (0.4 mg/kg)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 16873702

Group type: EXPERIMENTAL
Intervention: rhIGF-I/IGFBP-3 (0.1-0.8 mg x kg(-1) x day(-1))
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: rhIGF-I/IGFBP-3
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 12904184

Group type: EXPERIMENTAL
Intervention: Natural sounds played to 29 patients using headphones during surgery (S group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Dummy open-type headphones fitted to 30 patients (N group)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Natural sounds played to 29 patients (S group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Dummy open-type headphones (N group)
Number of subjects: 59
Study: 10678614

Group type: EXPERIMENTAL
Intervention: High-dose fluticasone propionate (1,000 microg x day(‐1))
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (100 microg x day(‐1))
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (after 6 weeks of FP treatment)
Number of subjects: 24
Study: 9042816

Group type: EXPERIMENTAL
Intervention: beta-carotene (15 mg daily)
Number of subjects: 25

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study: 8366412

Group type: EXPERIMENTAL
Intervention: Collagen membrane barrier therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no collagen membrane barrier)
Number of subjects: 38
Study: 3788816

Group type: EXPERIMENTAL
Intervention: 150 mg of dipyridamole
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 25 mg of ASA
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 150 mg of dipyridamole and 25 mg of ASA together
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 30209014

Group type: EXPERIMENTAL
Intervention: Medial pivot insert (MP group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Symmetrical dish insert (SD group)
Number of subjects: 70
Study: 27537372

Group type: EXPERIMENTAL
Intervention: Angle-modified double-lumen tube (Group M)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Non-angle-modified double-lumen tube (Group N)
Number of subjects: 108
Study: 24287186

Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 vaccine
Number of subjects: 30527

Group type: COMPARATOR
Intervention: Control (hepatitis B or A vaccine)
Number of subjects: 30527

Group type: EXPERIMENTAL
Intervention: PHiD‐CV10 vaccine (catch-up schedules)
Number of subjects: 30527
Study: 23421308

Group type: EXPERIMENTAL
Intervention: Aloe vera toothpaste
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control toothpaste
Number of subjects: 15
Study: 20207239

Group type: EXPERIMENTAL
Intervention: Vitamin C (1 g) and Vitamin E (400 IU) supplementation
Number of subjects: 2363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2363
Study: 18279583

Group type: EXPERIMENTAL
Intervention: Topical diclofenac
Number of subjects: 3000
Study: 16102633

Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins with preoperative duplex scanning
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins without perforator ligation
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Surgery for primary varicose veins
Number of subjects: 293
Study: 12450888

Group type: EXPERIMENTAL
Intervention: Mixed alpha‐ plus gamma‐tocotrienol supplement
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: P25‐complex tocotrienol
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: High gamma‐tocotrienol
Number of subjects: 67

Group type: COMPARATOR
Intervention: Safflower oil placebo
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Overall tocotrienol supplementation
Number of subjects: 67
Study: 10050739

Group type: EXPERIMENTAL
Intervention: Fat-suppressed T1-weighted 3D-Gradient Echo (GE) images
Number of subjects: 20

Group type: COMPARATOR
Intervention: T1-weighted SE images post-contrast (with gadolinium)
Number of subjects: 20
Study: 7669470

Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane concentrations (low: 0.10‐0.14 vol%, middle: 0.16‐0.20 vol%, high: 0.22‐0.26 vol%)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Subanaesthetic isoflurane concentrations (low, middle, high)
Number of subjects: 12
Study: 2392277

Group type: EXPERIMENTAL
Intervention: pindolol 1%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: timolol 0.5%
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 7439253

Group type: EXPERIMENTAL
Intervention: Phenazone (1.0 g X 4 for 2 days, then 0.5 g X 4 for the next 2 days)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Phenazone
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31030626

Group type: EXPERIMENTAL
Intervention: PrEP self-efficacy
Number of subjects: 1884
Study: 28181266

Group type: EXPERIMENTAL
Intervention: Isotonic resistance training at 15° to 30° ankle plantarflexion at low intensity for 4 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study: 27520367

Group type: EXPERIMENTAL
Intervention: Vibro-acupuncture (VA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Manual acupuncture (MA)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 30
Study: 24741050

Group type: EXPERIMENTAL
Intervention: Alprazolam (single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Zolpidem (single oral dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baclofen (GABABR agonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam (classical benzodiazepine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22137364

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Stress Reduction (MBSR)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 63
Study: 20146343

Group type: EXPERIMENTAL
Intervention: Frozen section and imprint cytology
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Hematoxylin‐eosin stain
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Serial step sectioning (SSS) with hematoxylin‐eosin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Frozen section
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: SSS with hematoxylin‐eosin stain
Number of subjects: 80
Study: 17618955

Group type: EXPERIMENTAL
Intervention: 10 g of a mix of inulin and oligofructose (9 subjects)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (8 subjects)
Number of subjects: 17
Study: 15632028

Group type: EXPERIMENTAL
Intervention: 3D gated acquisitions (3D-10)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3D gated acquisitions (3D-5)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 2D gated acquisitions (2D-G)
Number of subjects: 21

Group type: COMPARATOR
Intervention: 2D non-gated acquisitions (2D-NG)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Visual assessment of viability
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Left ventricular ejection fraction
Number of subjects: 21
Study: 12358656

Group type: EXPERIMENTAL
Intervention: Intravenous midazolam 0.1 mg.kg‐1
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Propofol 2 mg.kg‐1
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 10529545

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 522

Group type: COMPARATOR
Intervention: Naratriptan 2.5 mg
Number of subjects: 522
Study: 7782427

Group type: EXPERIMENTAL
Intervention: D‐tryptophan‐6‐luteinizing hormone‐releasing hormone (D‐Trp‐6‐LHRH) depot (Decapeptyl 3.75) for 6 months
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive containing 30 micrograms of ethinyl oestradiol plus 150 micrograms of desogestrel for 12 months after GnRHa therapy
Number of subjects: 6
Study: 2182301

Group type: EXPERIMENTAL
Intervention: CPAP mask combined with regional analgesia (n = 36)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Endotracheal intubation and mechanical ventilation with PEEP (n = 33)
Number of subjects: 69
Study: 6793277

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Promethazine
Number of subjects: 6
Study: 31846501

Group type: EXPERIMENTAL
Intervention: Coach2Move strategy
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care physical therapy
Number of subjects: 400
Study: 30565544

Group type: EXPERIMENTAL
Intervention: New care model mediated by care managers
Number of subjects: 248

Group type: COMPARATOR
Intervention: Usual treatment by primary care physician
Number of subjects: 248
Study: 27405752

Group type: EXPERIMENTAL
Intervention: Referral strategy for axSpA in CLBP patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care for CLBP patients
Number of subjects: 0
Study: 25038977

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX) 30, 50 or 70 mg/day
Number of subjects: 267

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (LDX)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Atomoxetine (ATX)
Number of subjects: 267
Study: 22338862

Group type: EXPERIMENTAL
Intervention: Airtraq with Gum Elastic Bougie (ATQ + GEB)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Airtraq without Gum Elastic Bougie (ATQ)
Number of subjects: 141
Study: 20691825

Group type: EXPERIMENTAL
Intervention: hs‐cTnT assay
Number of subjects: 1452

Group type: COMPARATOR
Intervention: cTnT assay
Number of subjects: 1452

Group type: COMPARATOR
Intervention: Negative for both assays
Number of subjects: 1452
Study: 19025526

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium sulfate (MgSO(4)) infusion
Number of subjects: 218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 218
Study: 15691562

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 137
Study: 14500119

Group type: EXPERIMENTAL
Intervention: High-frequency rTMS of the dominant dorsolateral prefrontal cortex
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 12
Study: 10878653

Group type: EXPERIMENTAL
Intervention: Lycopene (13.3 mg)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Carotene mixture (11.9 mg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 9368829

Group type: EXPERIMENTAL
Intervention: High carbohydrate foods (PWS)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Obese controls
Number of subjects: 38
Study: 1473308

Group type: EXPERIMENTAL
Intervention: Low bradycardia pacing rate (45.7 +/- 4 beats/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: High bradycardia pacing rate (85.1 +/- 2 beats/min)
Number of subjects: 10
Study: 4020675

Group type: EXPERIMENTAL
Intervention: Acetaminophen with probenecid (500 mg every 6 hr)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Acetaminophen without probenecid
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lorazepam with probenecid (500 mg every 6 hr)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lorazepam without probenecid
Number of subjects: 20
Study: 30863396

Group type: EXPERIMENTAL
Intervention: Anti-BP180 autoantibodies measured by ELISA
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sera reacting with 180-kDa proteins from human epidermal extract
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Recognition of human recombinant full length BP180 and NC16A
Number of subjects: 100
Study: 30672229

Group type: EXPERIMENTAL
Intervention: Staged acupuncture combined with conventional rehabilitation
Number of subjects: 145

Group type: COMPARATOR
Intervention: Traditional acupuncture combined with conventional rehabilitation
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional rehabilitation
Number of subjects: 145
Study: 27346746

Group type: EXPERIMENTAL
Intervention: Obinutuzumab plus chlorambucil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chlorambucil alone
Number of subjects: 0
Study: 23455717

Group type: EXPERIMENTAL
Intervention: FLOT (biweekly oxaliplatin plus 5‐fluorouracil continuous infusion and folinic acid plus docetaxel 50 mg/m²)
Number of subjects: 143

Group type: COMPARATOR
Intervention: FLO (biweekly oxaliplatin plus 5‐fluorouracil continuous infusion and folinic acid)
Number of subjects: 143
Study: 23327127

Group type: EXPERIMENTAL
Intervention: Group D (diazepam 0.2 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Group K (ketamine 5% 30 mg/kg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Group KD (ketamine 5% 10 mg/kg + diazepam 0.2 mg/kg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Group C (normal saline)
Number of subjects: 32
Study: 20512109

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum with CPP-ACP (Group A)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sugar-free chewing gum without CPP-ACP (Group C)
Number of subjects: 88

Group type: COMPARATOR
Intervention: No desensitising agent (Group B)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 88
Study: 18996251

Group type: EXPERIMENTAL
Intervention: Pilates imprint exercise performed correctly (with abdominal drawing-in)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hundreds A exercise performed correctly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Hundreds B exercise performed correctly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Leg-circle exercise performed correctly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Roll-up exercise performed correctly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Mat imprint exercise performed correctly
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Reformer hundreds B exercise
Number of subjects: 26

Group type: COMPARATOR
Intervention: Incorrect imprint exercise
Number of subjects: 26
Study: 15879806

Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: terazosin
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: doxazosin
Number of subjects: 114

Group type: COMPARATOR
Intervention: control group
Number of subjects: 114
Study: 12641628

Group type: EXPERIMENTAL
Intervention: High-dose adjuvant I-131 therapy
Number of subjects: 342

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 342
Study: 10347109

Group type: EXPERIMENTAL
Intervention: Midodrine and octreotide with 20% human albumin solution (50 to 100 mL daily for 20 days)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Dopamine (2‐4 micrograms/kg/min) with the same daily amount of albumin
Number of subjects: 13
Study: 8702034

Group type: EXPERIMENTAL
Intervention: Mefloquine (MQ) regimen
Number of subjects: 3380

Group type: COMPARATOR
Intervention: Chloroquine (CQ) regimen
Number of subjects: 3380
Study: 1843090

Group type: EXPERIMENTAL
Intervention: Furazolidone
Number of subjects: 31
Study: 6362840

Group type: EXPERIMENTAL
Intervention: Local excision plus cobalt irradiation
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Nodal area irradiation
Number of subjects: 179

Group type: COMPARATOR
Intervention: Mastectomy
Number of subjects: 179